Colesevelam improved lipoprotein particle subclasses in patients with prediabetes and primary hyperlipidaemia
Background: A randomised, double-blind, placebo-controlled study evaluated lipid- and glucose-lowering effects of colesevelam in patients with prediabetes and primary hyperlipidaemia. We report the effect of colesevelam on lipoprotein particle concentration and particle size (determined by nuclear m...
| Autores Principales: | , , , , |
|---|---|
| Formato: | Artículo (Article) |
| Lenguaje: | Inglés (English) |
| Publicado: |
2013
|
| Materias: | |
| Acceso en línea: | https://repository.urosario.edu.co/handle/10336/23847 https://doi.org/10.1177/1479164112461657 |